Noninvasive Evaluation of Liver Disease Severity

Clinics in Liver Disease

Volumn 10, Issue 3, 2006, Pages 535-562

  Hoefs, John Carl ^a   Chen, Phillip T ^a   Lizotte, Paul ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 METHYL N PYRIDOXYLTRYPTOPHAN TECHNETIUM TC 99M; GALACTOSYL HUMAN SERUM ALBUMIN TC 99M; RECOMBINANT INTERFERON; TECHNETIUM SULFUR COLLOID TC 99M; TECHNETIUM TIN COLLOID TC 99M; TRACER;

ASIALOGLYCOPROTEIN RECEPTOR SCAN; BLOOD EXAMINATION; BREATH ANALYSIS; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DISEASE SEVERITY; FIBROSCAN; FREQUENCY MODULATED ULTRASOUND; HEPATITIS C; HUMAN; LIVER BIOPSY; LIVER CANCER; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FIBROSIS; LIVER FUNCTION; LIVER FUNCTION TEST; NON INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE IMAGING; QUANTITATIVE LIVER SPLEEN SCAN; REVIEW; SCINTIGRAPHY; SCREENING TEST; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPLENOMEGALY; VARICOSIS;

ASIALOGLYCOPROTEIN RECEPTOR; FEMALE; HUMANS; LIVER DISEASES; LIVER FUNCTION TESTS; MAGNETIC RESONANCE IMAGING; MALE; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33845294741     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cld.2006.08.008     Document Type: Review

References (108)

1. Abdi W., Millan J.C., and Mezey E. Sampling variability on percutaneous liver biopsy. Arch Intern Med 139 (1979) 667-676
2. Maharaj B., Maharaj R.J., Leary W.P., et al. Sampling variability and the influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet 1 (1986) 523-525
3. Bedossa P., Dargere D., and Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 38 6 (2003) 1449-1457
4. Nord J.H. Biopsy diagnosis of cirrhosis: blind percutaneous versus guided direct vision techniques. A review. Gastrointest Endosc 28 (1982) 102-104
5. Hoefs J.C., Wang F., Kanel G., et al. The liver-spleen scan as a quantitative liver function test: correlation with liver severity at peritoneoscopy. Hepatology 22 (1995) 1113-1121
6. Hoefs J.C., Wang F., and Kanel G. Functional measurement of the non-fibrotic hepatic mass in cirrhotic patient. Am J Gastroenterol 92 (1997) 2054-2058
7. Bravo A.A., Sheth S.G., and Chopra S. Liver biopsy. N Engl J Med 344 (2001) 495-500
8. Soloway R.D., Baggenstoss A.H., Schoenfield L.J., et al. Observer error and sampling variability tested in evaluation of hepatitis and cirrhosis by liver biopsy. Am J Dig Dis 16 (1971) 1082-1086
9. Poynard T., Ratziu V., and Bedossa P. Appropriateness of liver biopsy. Can J Gastroenterol 14 (2000) 543-548
10. Cadranel J.F., Rufat P., and Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. Hepatology 32 (2000) 477-481
11. Friedman S.L. Liver fibrosis-from bench to bedside. J Hepatol 38 (2003) S38-S53
12. Hoefs J.C., Green G., Reynolds T.B., et al. Mechanism for the abnormal liver scan in acute alcoholic liver injury. Am J Gastroenterol 79 12 (1984) 950-958
13. Hoefs J., Chang K., Wang F., et al. The perfused Kupffer cell mass: correlation with histology and severity of CLD. Dig Dis Sci 40 (1995) 552-560
14. Horisawa M., Goldstein G., Waxman A., et al. The abnormal hepatic scan of chronic liver disease: its relationship to hepatic hemodynamics and colloid extraction. Gastroenterology 71 (1976) 210-213
15. Zuckerman E., Lobodin G., Sabo E., et al. Quantitative liver-spleen scan using single photon emission computerized tomography (SPECT) for assessment of hepatic function in cirrhotic patients. J Hepatol 39 (2003) 326-332
16. Groshar D., Slobodin G., and Zuckerman E. Quantitation of liver and spleen uptake of Tc-99m-phytate-colloid using SPECT: detection of liver cirrhosis. J Nucl Med 43 (2002) 321-327
17. Triger D.R., Bialas C., Segasby C.A., et al. Hepatic reticuloendothelial function: a correlation of radioisotopic and immunohistochemical assessment. Liver 9 (1989) 86-92
18. Hoefs J.C., Sheikh M., and Guererro H.J. Ry sl. Factors affecting the quantitative liver spleen scan in normal individuals. Dig Dis Sci 50 (2005) 283-289
19. George E.A., Hendershott L.R., Klos D.J., et al. Mechanism of hepatic extraction of gelatinized 99m technetium sulfur colloid. Eur J Nucl Med 5 (1980) 241-245
20. Frier M., Griffiths P., and Ramsey A. The biological fate of sulphur colloid. Eur J Nucl Med 6 (1981) 371-374
21. Noronha O.P., Sewatkar A.B., and Ganatra R.D. Factors affecting the preparation of 99mTc-sulfur colloid. Eur J Nucl Med 3 (1978) 47-54
22. Dobson E.L., and Jones H.B. The behaviour of intravenously injected particulate material: its rate of disappearance from the blood stream as a measure of liver blood flow. Acta Med Scand 144 (1952) 273S
23. Vetter H., Falkner R., and Neumayer A. The disappearance rate of colloidal and radiogold from the circulation and its application to the estimation of liver blood flow in normal and cirrhotic subjects. J Clin Invest 33 (1954) 1594
24. Saba T.M. Physiology and pathophysiology of the reticuloendothelial system. Arch Inten Med 126 (1970) 1031-1052
25. Basista M.H., Stauber R.E., Van Thiel D.H., et al. Effect of isolated portal hypertension on Kupffer cell function. Dig Dis Sci 39 (1994) 46-50
26. Atkins H.L., Hauser W., and Richards P. Factors affecting distribution of technetium-sulfur colloid. J Reticuloendothel Soc 8 (1970) 76-84
27. Rosenthal S.N., and Bardfeld P.A. An evaluation of methods for sizing radiocolloidal particles. Nucl Med Commun 7 (1986) 511-517
28. Frier M., Griffiths P., and Ramsey A. The biological fate of sulphur colloid. Eur J Nucl Med 6 (1981) 371-374
29. Bergqvist L., Sundberg R., Ryden S., et al. The "critical colloid dose" in studies of reticuloendothelial function. J Nuc Med 28 (1998) 1424-1429
30. Kloiber R, Damtew B, Rosenthall L. Crossover study comparing the effect of particle size on the distribution of radiocolloid in patients. Clin Nucl Med 19816:204-6
31. Krogsgaard O.W. Technetium-99m-sulfur colloid. In vitro studies of various commercial kits. Eur J Nucl Med 1 (1976) 31-35
32. Geslien G.E., Pinsky S.M., Poth R.K., et al. The sensitivity and specificity of Tc-sulfur colloid liver imaging in diffuse hepatocellular disease. Radiology 118 (1976) 115-119
33. Hoefs J.C., Wang F., Lilien D., et al. A novel, simple method of functional spleen volume calculation by liver-spleen scan. J Nucl Med 40 (1999) 1745-1755
34. Everson G., Kugelmas M., DeSanto J., et al. Quantitative tests (QLFTS) detect impaired hepatic function in a high proportion of chronic hepatitis C patients with fibrosis or compensated cirrhosis and may predict risk of cirrhosis, splenomegaly, and varices. [abstract]. Hepatology 38 (2003) 309
35. Everson E., Schiffman M., Hoefs J., et al. Quantitative liver function tests predict sustained virologic response to retreatment with peginterferon alfa-2a plus ribavirin: results of the lead-in phase of the halt-C trial. [abstract]. Hepatology 40 (2004) 313A
36. Shiffman M.L., Di Bisceglie A.M., Lindsay K.L., et al. Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who failed prior treatment. Gastroenterology 126 (2004) 1015-1023
37. Lorenzen J., Sinkus R., Biesterfeldt M., et al. Menstrual-cycle dependence of breast parenchyma elasticity: estimation with magnetic resonance elastography of breast tissue during the menstrual cycle. Invest Radiol 38 (2003) 236-240
38. Sasaki N., Shiomi S., Iwata Y., et al. Clinical usefulness of scintigraphy with 99mTc-galactosyl-human serum albumin for prognosis of cirrhosis of the liver. J Nucl Med 40 10 (1999) 1652-1656
39. Kitano S., and Kim Y.I. ICG clearance in assessing cirrhotic patients with hepatocellular carcinoma for major hepatic resection. HPB Surg 10 (1997) 182-183
40. Matsumata T., Kanematsu T., Yoshida Y., et al. The indocyanine green test enables prediction of postoperative complications after hepatic resection. World J Surg 11 (1987) 678-681
41. Torzilli G., Makuuchi M., Inoue K., et al. No-mortality liver resection for hepatocellular carcinoma in cirrhotic and non-cirrhotic patients. Arch Surg 134 (1999) 984-992
42. Ashwell G., and Morell A.G. The role of surface carbohydrates in the hepatic recognition and transport of circulating glycoproteins. Adv Enzymol Relat Areas Mol Biol 41 (1974) 99-128
43. Spiess M. The asialoglycoprotein receptor: a model for endocytic transport receptors. Biochemistry 29 (1990) 10009-10018
44. Daniels C.K., Schmucker D.L., and Jones A.L. Hepatic asialoglycoprotein receptor-mediated binding of human polymeric immunoglobulin A. Hepatology 9 (1989) 229-234
45. Rotundo R.F., Vincent P.A., McKeown-Longo P.J., et al. Hepatic fibronectin matrix turnover in rats: involvement of the asialoglycoprotein receptor. Am J Physiol 277 (1999) G1189-G1199
46. McVicker B.L., Tuma D.J., Kubik J.A., et al. The effect of ethanol asialoglycoprotein receptor-mediated phagocytosis of apoptotic cells by rat hepatocytes. Hepatology 36 (2002) 1478-1487
47. Dini L., Autuori F., Lentini A., et al. The clearance of apoptotic cells in the liver is mediated by the asialoglycoprotein receptor. FEBS Lett 296 (1992) 174-178
48. Ishibashi S., Perrey S., Chen Z., et al. Role of the low density lipoprotein (LDL) receptor pathway in the metabolism of chylomicron remnants. A quantitative study in knockout mice lacking the LDL receptor, apolipoprotein E, or both. J Biol Chem 271 (1996) 22422-22427
49. Eckelman W.C., Reba R.C., Gibson R.E., et al. Receptor-binding radiotracers: a class of potential radiopharmaceuticals. J Nucl Med 20 4 (1979) 350-357
50. Kudo M., Toda A., Ikekubo K., et al. Functional hepatic imaging with receptor-binding radiopharmaceutical: clinical potential as a measure of functioning hepatocyte mass. Gastroenterol Jpn 26 (1991) 734-741
51. Vera, Hoh, and Mendez. Scintigraphic measurement of liver function. In: Ell P., and Gambhir S. (Eds). Nuclear medicine in clinical diagnosis and treatment. 3rd edition (2004), Churchil Livingstone, New York 846-855
52. Kudo M., Ikekubo K., Todo A., et al. Hepatic receptor imaging with Tc-99m GSA: estimates of liver function in acute liver disease. Nippon Shokakibyo Gakkai Zasshi 89 3 (1992) 616-626
53. Kinoshita K., Ukikusa M., Iwaisako K., et al. Preoperative assessment of hepatic function: utility of a new convenient two-compartment model analysis using galactosyl human albumin scintigraphy. J Gastroenterol Hepatol 18 (2003) 99-104
54. Matsuzaki S., Onda M., Tajiri T., et al. Hepatic lobar differences in progression of chronic liver disease: correlation of asialoglycoprotein scintigraphy and hepatic functional reserve. Hepatology 25 (1997) 828-832
55. Sugahara K., Togashi H., Takahashi K., et al. Separate analysis of asialoglycoprotein receptors in the right and left hepatic lobes using 99mTc-GSA SPECT. Hepatology 38 (2003) 1401-1409
56. Onodera Y., Takahashi K., Togashi T., et al. Clinical assessment of hepatic functional reserve using to prognosticate chronic hepatic diseases-validation of the use of SPECT and a new indicator. Ann Nucl Med 17 3 (2003) 181-188
57. Iguchi T., Sato S., Kouno Y., et al. Comparison of Tc-99m-GSA scintigraphy with hepatic fibrosis and regeneration in patients with hepatectomy. Ann Nucl Med 17 3 (2003) 227-233
58. Kokudo N., Vera D., Tada K., et al. Predictors of successful hepatic resection: prognostic usefulness of hepatic asialoglycoprotein receptor analysis. World J Surg 26 (2002) 1342-1347
59. Kwon A., Matsui Y., Kaibori M., et al. Safety of hepatectomy for living donors as evaluated using asialoscintigraphy. Transplant Proc 36 (2004) 2239-2242
60. Tanaka A., Shinohara H., Hatano E., et al. Perioperative changes in hepatic function as assessed by asialoglycoprotein receptor indices by technetium 99m galactosyl human serum albumin. Hepatogastroenterology 46 25 (1999) 369-375
61. Satoh K., Yamamoto Y., Nishiyama Y., et al. 99m Tc-GSA liver dynamic SPECT for the preoperative assessment of hepatectomy. Ann Nucl Med 17 1 (2003) 61-67
62. Mitomo O., Tsunoda T., Nakamura K., et al. Quantification of intrahepatic non-uniform distributions for assessing impaired function of liver using 99Tcm- DTPA-galactosyl serum albumin liver SPECT scintigraphy. Nucl Med Commun 22 5 (2001) 505-512
63. Pimstone N., Stadalnk R., Vera D., et al. Evaluation of hepatocellular function by way of receptor-mediated uptake of technetium-99m-labeled asialoglycoprotein analog. Hepatology 20 (1994) 917-923
64. Koreeda C., Kawa S.K., Takasu M., et al. A study of colloidal scintigraphy in alcoholic liver diseases: discordance from asialo-scintigraphic findings. Alcohol Clin Exp Res 24 4 Suppl (2000) 43S-47S
65. Shuke N., Aburano T., Nakajima K., et al. [The utility of quantitative 99mTc-GSA liver scintigraphy in the evaluation of hepatic functional reserve: comparison with 99mTc-PMT and 99mTc-Sn colloid]. Kaku Igaku 29 5 (1992) 573-584 [in Japanese]
66. Kawamura E., Shiomi S., Ishizu H., et al. Natural course of changes in hepatic functional reserve scintigraphy with GSA. Hepatol Res 27 2 (2003) 129-135
67. Kira T., Tomiguchi S., Takahashi M., et al. Correlation of 99mTc-GSA hepatic scintigraphy with liver biopsies in patients with chronic active hepatitis type C. Radiat Med 17 2 (1999) 125-130
68. Duerinckx A.J., Ferrari L., Hoefs J.C., et al. Estimation of acoustic attenuation in liver using one megabyte of data and the zero crossings technique. Ultrasonics 24 (1986) 325-332
69. Duerinckx A.J., Rosenberg K., Hoefs J.C., et al. In-vivo acoustic attenuation in liver: correlations with histology and blood tests. Ultrasound Med Biol 14 5 (1988) 405-413
70. Hoefs J.C., Aufrichtig D., Lottenberg S., et al. A non-invasive evaluation of hepatic fibrosis using frequency demodulation of ultrasound signals. Dig Dis Sci 31 (1985) 1046-1055
71. Aufrichtig D., Lottenberg S., Hoefs J., et al. Frequency demodulation/ultrasound imaging-an evaluation in the liver. Radiology 160 1 (1986) 59-64
72. Ophir J., Cespedes E.I., Ponnekanti H., et al. Elastography: a method for imaging the elasticity in biological tissues. Ultrason Imaging 13 (1991) 111-134
73. Cespedes I., Ophir J., Ponnekanti H., et al. Elastography: elasticity imaging using ultrasound with application to muscle and breast in vivo. Ultrason Imaging 15 (1993) 73-88
74. Krouskop T.A., Wheeler T.M., Kallel F., et al. Elastic moduli of breast and prostate tissue under compression. Ultrason Imaging 20 (1998) 260-274
75. Muthupillai R., Lomas D.J., Rossman P.J., et al. Magnetic resonance elastography by direct visualization of propagating acoustic strain waves. Science 269 (1995) 1854-1857
76. Lerner R.M., and Parker K.J. Sono-elasticity imaging. In: Kessler L.W. (Ed). Acoust Imaging (1988), Plenum Co., New York 317-327
77. Levinson S.F., Shinagawa M., and Sato T. Sonoelastic determination of human skeletal muscle elasticity. J Biomech 28 (1995) 1145-1154
78. Yamakoshi Y, Suzuki M, Sato T. Imaging the elastic properties using low frequency vibration and probing ultrasonic wave. Presented at the Japanese Meeting of Applied Physics. Tokyo. 1987.
79. Yamakoshi Y., Sato J., and Sato T. Ultrasonic imaging of internal vibration of soft tissue under forced vibration. IEEE Trans Ultrason Ferroelec Freq Control 37 (1990) 45-53
80. Sanada M., Ebara M., Fukuda H., et al. Clinical evaluation of sonoelasticity measurement in liver using ultrasonic imaging of internal forced low-frequency vibration. Ultrasound Med Biol 26 (2000) 1455-1460
81. Nightingale K.R., Palmeri N.L., Nightingale R.W., et al. On the feasibility of remote palpation using acoustic radiation force. J Acoust Soc Am 110 (2001) 625-634
82. Rudenko O.V., Sarvazyan A.P., and Emilianov S.Y. Acoustic radiation force and streaming induced by focused nonlinear ultrasound in a dissipative medium. J Acoust Soc Am 99 (1996) 2791-2798
83. Sarvazyan A.P. A new approach to remote ultrasonic evaluation of viscoelastic properties of tissues for diagnostics and healing monitoring. Abstract of ARPA/ONR Medical Ultrasonic Imaging Technology Workshop. Landsdown (VA):1995. p. 24-6.
84. Sandrin L., Catheline S., Tanter M., et al. Time-resolved pulsed elastography. Ultrason Imaging 21 (1999) 259-272
85. Sandrin L., Tanter M., Catheline S., et al. Shear modulus imaging with 2D transient elastography. IEEE Trans Ultrason Ferroelec Freq Control 49 (2002) 426-435
86. Sandrin L., Tanter M., Gennisson J.L., et al. Shear elasticity probe for soft tissues with 1D transient elastography. IEEE Trans Ultrason Ferroelec Freq Control 49 (2002) 436-446
87. Yeh W.C., Li P.C., Jeng Y.M., et al. Elastic modulus measurements of human liver and correlation with pathology. Ultrasound Med Biol 28 (2002) 467-474
88. Sandrin L., Fourquet B., Hasquenoph J.M., et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 29 (2003) 1705-1713
89. Colletta C., Smirne C., Fabris C., et al. Value of two noninvasive methods to detect progression of fibrosis among HCV carriers with normal aminotransferases. Hepatology 42 4 (2005) 838-845
90. Castera L., Vergniol J., Foucher J., et al. Prospective comparison of transient elastography, FibroTest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 128 (2005) 343-350
91. Ziol M., Handra-Luca A., Kettaneh A., et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 41 (2004) 48-54
92. Foucher J., Chanteloup E., Vergniol J., et al. Diagnosis of cirrhosis by transient elastography (Fibroscan): a prospective study. Gut 55 (2006) 403-408
93. Gur D., Good W.F., Herbert D.L., et al. Blood flow mapping in the human liver by the xenon/CT method. J Comput Assist Tomogr 9 3 (1985) 447-450
94. Miles K.A., Hayball M.P., and Dixon A.K. Functional images of hepatic perfusion obtained with dynamic CT. Radiology 188 (1993) 405-411
95. Van Beers B.E., Leconte I., Materne R., et al. Hepatic perfusion parameters in chronic liver disease: dynamic CT measurements correlated with disease severity. AJR Am J Roentgenol 176 (2001) 667-673
96. Nakashige A., Horiguchi J., Tamura A., et al. Quantitative measurement of hepatic portal perfusion by multidetector row CT with compensation for respiratory misregistration. Br J Radiol 77 921 (2004) 728-734
97. Annet L., Materne R., Danse E., et al. Hepatic flow parameters measured with MR imaging and Doppler US: correlations with degree of cirrhosis and portal hypertension. Radiology 229 (2003) 409-414
98. Shrestha R., McKinley C., Showalter R., et al. Quantitative liver function tests (QLFTs) define the functional severity of liver disease in early stage cirrhosis. Liver Transpl Surg 3 (1997) 166-173
99. Everson G.T. Steady-state kinetics of serum bile acids in healthy human subjects: single and dual isotope techniques using stable isotopes and mass spectrometry. J Lipid Res 28 (1987) 238-252
100. Rector Jr. W.G., Lewis F., Robertson A.D., et al. Renal sodium retention complicating alcoholic liver disease: relation to portosystemic shunting and liver function. Hepatology 12 (1990) 455-459
101. Schmidt L.E., Rasmussen A., Kirkegaard P., et al. Relationship between postoperative erythromycin breath test and early morbidity in liver transplant recipients. Transplantation 76 (2003) 358-363
102. Watkins P.B., Murray S., Winkelman L., et al. Erythromycin breath test as an assay of glucocorticoid-inducible liver cytochromes P-450. Studies in rats and patients. J Clin Invest 83 (1989) 688-697
103. O'Neal C.L., and Poklis A. Sensitive HPLC for simultaneous quantification of lidocaine and its metabolites, monoethylglycinexylidide and glycinexylidide, in serum. Clin Chem 42 (1996) 330-331
104. Vilstrup H. The galactose elimination capacity as a quantitative measure of liver function in acute carbon tetrachloride intoxication of rats. Eur J Clin Invest 8 (1978) 317-319
105. Lindskov J. The quantitative liver function as measured by the galactose elimination capacity. Acta Med Scand 212 (1982) 303-308
106. Limanond P., Raman S.S., Ghobrial R.M., et al. Preoperative imaging in adult-to-adult living related liver transplant donors: what surgeons want to know. J Comput Assist Tomogr 28 2 (2004) 149-157
107. McCrea J., Prueksaritanont T., Gertz B.J., et al. Concurrent administration of the erythromycin breath test (EBT) and oral midazolam as in vivo probes for CYP3A activity. J Clin Pharmacol 39 12 (1999) 1212-1220
108. Schneider P. Preoperative assessment of liver function. Surg Clin North Am 84 2 (2004) 355-373